Overview

  • Product name
    Riluzole (PK 26124)
  • Description
    Neuroprotective agent. Modulates glutamate transmission.
  • Alternative names
    • PK 26124
  • Biological description
    Neuroprotective agent with anticonvulsant, sedative, anxiolytic, anti-ischemic and anesthetic properties. Inhibits glutamate release, enhances glutamate uptake, blocks voltage-dependent Na+ channels, antagonises NMDA receptors and inhibits GABA uptake. Reported to offer neuroprotection and some therapeutic potential for amyotrophic lateral sclerosis and Huntingdon's disease.
  • Purity
    > 99%

Properties

References

This product has been referenced in:
  • Fumagalli E  et al. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol 578:171-6 (2008). Read more (PubMed: 18036519) »
  • Lamanauskas N & Nistri A Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro. Eur J Neurosci 27:2501-14 (2008). Read more (PubMed: 18445055) »
  • Doble A The pharmacology and mechanism of action of riluzole. Neurology 47:S233-41 (1996). Read more (PubMed: 8959995) »

See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120272.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up